In the validation set, we further compared the differences in VEGFR signature scores and angiogenic activity signature scores of IMECs between tumor tissue (treated group, n = 17; untreated group, n = 10) and paracancer tissue (n = 13) (Figure 8F–I). This evidence concerns the gene KDR and neoplasm.